CCHR Warns Ongoing Psychiatric Drug Approvals Persist Despite Documented Risks
LOS ANGELES, Calif., Feb. 18, 2026 (SEND2PRESS NEWSWIRE) — More than 30 years after early warnings about antidepressant-linked suicidality and violence were downplayed, new peer-reviewed studies are again raising concerns about psychiatric drug oversight. The mental health watchdog Citizens Commission on Human Rights International (CCHR) says high-risk drugs are seldom removed from the market and argues that stronger safeguards are urgently needed.